ATC code J02

ATC code J02 is a section of the Anatomical Therapeutic Chemical Classification System (ATC), which is used for the classification of drugs and other medical products. This specific code pertains to antimycotics for systemic use. The ATC system is maintained by the World Health Organization (WHO) and is widely used for drug classification in both clinical and research settings.

Classification

The ATC code J02 is divided into several subcategories, each representing a different type of systemic antimycotic. These subcategories include:

• J02A - Antimycotics for systemic use
  • J02AA - Antibiotics for systemic use
  • J02AB - Imidazole derivatives
  • J02AC - Triazole derivatives
  • J02AX - Other antimycotics for systemic use

J02A: Antimycotics for Systemic Use

This category includes drugs that are used to treat systemic fungal infections. These infections can affect various parts of the body, including the bloodstream, lungs, and other internal organs.

J02AA: Antibiotics for Systemic Use

This subcategory includes antibiotics that are specifically used to treat fungal infections. These drugs are distinct from antibiotics used to treat bacterial infections.

J02AB: Imidazole Derivatives

Imidazole derivatives are a class of antifungal drugs that inhibit the synthesis of ergosterol, an essential component of fungal cell membranes. Examples include ketoconazole and miconazole.

J02AC: Triazole Derivatives

Triazole derivatives are another class of antifungal drugs that also inhibit ergosterol synthesis. They are generally more effective and have fewer side effects compared to imidazole derivatives. Examples include fluconazole and itraconazole.

J02AX: Other Antimycotics for Systemic Use

This subcategory includes other types of systemic antifungal drugs that do not fall into the previous categories. Examples include amphotericin B and flucytosine.

Clinical Use

Systemic antimycotics are used to treat a variety of fungal infections, including candidiasis, aspergillosis, and cryptococcosis. These infections can be life-threatening, especially in immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy.

Side Effects

The side effects of systemic antimycotics can vary depending on the specific drug and the patient's overall health. Common side effects include nausea, vomiting, and liver toxicity. Long-term use can also lead to resistance.

See Also

• ATC code J
• Antifungal
• Systemic infection
• World Health Organization